Correction to: Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience. | LitMetric

A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 197

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3165
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 317
Function: require_once

Correction to: Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience. | LitMetric

Correction to: Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience.

Antonella Bruzzese , Giovanni Manfredi Assanto , Daniela Diverio , Luisa Quattrocchi , Daniela Carmini , Ursula La Rocca , Maria Stefania De Propris , Silvia Maria Trisolini , Mattia Brescini , Giulia Galassi , Walter Barberi , Anna Paola Iori

Bone Marrow Transplant

Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.

Published: June 2021

Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Download full-text PDF
Source

http://dx.doi.org/10.1038/s41409-021-01242-9 DOI Listing

Publication Analysis

Top Keywords

correction pre-emptive

4

pre-emptive sorafenib

4

sorafenib combined

4

combined dli

4

dli post

4

post hsct

4

hsct aml

4

aml flt3+

4

flt3+ single

4

single center

4

Similar Publications